A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in pre-clinical models.
Apr 28, 2026
0
3
University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help advance the treatment of lung diseases which affect men and women differently. The artificial lung ...
Apr 13, 2026
0
2
A new study from the University of Bergen shows that genes responsible for antibiotic resistance are present not only in individuals with lung disease, but also in people with healthy lungs. The researchers examined patients ...
Mar 31, 2026
0
1
Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The recent study published ...
Mar 30, 2026
0
11
Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and lung cancer. ...
Mar 9, 2026
0
9
Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue. While the early events that initiate this change are poorly understood, recent research suggests ...
Dec 10, 2025
0
26
Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening disease. It causes scarring of the connective tissue between the functional tissue of the lungs, leading ...
Nov 18, 2025
0
43
For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest ...
Oct 23, 2025
0
26
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF).
Oct 14, 2025
0
44
UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung transplants. The approach ...
Oct 10, 2025
0
16
